Pacira reported $10.23M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Astellas Pharma JPY 92.54B 29.02B Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.94B 6.69B Jun/2025
Ligand Pharmaceuticals USD 43.56M 79.78M Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025
Zoetis USD 1.02B 205M Jun/2025